Literature DB >> 35386486

Myeloproliferative Syndrome With Eosinophilia Associated With Translocation t(8; 13) and T-cell Lymphoblastic Lymphoma: A Case Report and Review of the Literature.

Lizeth Yamile Urrea Pineda1, Oliver Perilla2, Vanessa Santiago-Pacheco3, Simon Trujillo Montoya4.   

Abstract

The 8p11 myeloproliferative syndrome (EMS) is an aggressive neoplasm associated with chromosomal translocations involving the fibroblast growth factor receptor 1 tyrosine kinase gene on chromosome 8p11. We report the case of a 31-year-old man with no prior medical history who presents with two weeks of sore throat and cervical lymphadenopathy up to 5 cm. Initial peripheral blood examination showed leukocytosis with predominantly neutrophils and eosinophilia. A CT scan demonstrated mediastinal lymphadenopathies, liver enlargement and splenomegaly. An excisional biopsy of a cervical lymph node demonstrated findings consistent with a diagnosis of T-cell lymphoblastic lymphoma. Bone marrow aspirate and biopsy revealed hypercellular marrow with granulocytic predominance, left-shifted granulopoiesis, eosinophilia and the cytogenetic analysis showed the following karyotype: 46, XY, t(8;13). The final diagnosis was a myeloproliferative syndrome with eosinophilia related to t(8;13) and T-cell acute lymphoblastic lymphoma (8p11 myeloproliferative syndrome). We review the relevant literature about this unusual entity.
Copyright © 2022, Urrea Pineda et al.

Entities:  

Keywords:  eosinophilia; fibroblastic growth factor receptor-1 gene (fgfr1); lymphadenopathy; myeloid leukemia; precursor t-cell lymphoblastic leukemia-lymphoma

Year:  2022        PMID: 35386486      PMCID: PMC8969320          DOI: 10.7759/cureus.22734

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  15 in total

Review 1.  The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.

Authors:  D Macdonald; A Reiter; N C P Cross
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

2.  Lymphoblastic leukemia with marked eosinophilia: a report of two cases.

Authors:  G Spitzer; O M Garson
Journal:  Blood       Date:  1973-09       Impact factor: 22.113

3.  An atypical myeloproliferative disorder with t(8;13) (p11;q12): a third case.

Authors:  D Macdonald; S M Sheerin; N C Cross; A Spencer; J M Goldman
Journal:  Br J Haematol       Date:  1994-04       Impact factor: 6.998

4.  Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.

Authors:  Andrew Chase; Catherine Bryant; Joannah Score; Nicholas C P Cross
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

Review 5.  8p11 myeloproliferative syndrome: a review.

Authors:  Courtney C Jackson; L Jeffrey Medeiros; Roberto N Miranda
Journal:  Hum Pathol       Date:  2010-04       Impact factor: 3.466

Review 6.  8p11 associated myeloid/lymphoid neoplasms: An illustrative case report of this rare entity and review of literature.

Authors:  Naeem Jabbar; Neelum Mansoor; Momal Taimoor; Omer Jawed; Muhammad Shamvil Ashraf
Journal:  J Pak Med Assoc       Date:  2020-04       Impact factor: 0.781

7.  t(8;13)-positive bilineal lymphomas: report of 6 cases.

Authors:  Francisco Vega; L Jeffrey Medeiros; Rajayogesh Davuluri; Candy C Cromwell; Serhan Alkan; Lynne V Abruzzo
Journal:  Am J Surg Pathol       Date:  2008-01       Impact factor: 6.394

Review 8.  B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.

Authors:  Janese Trimaldi; Estrella M Carballido; Jeremy W Bowers; Arturo L Anguiano; Zhong J Zhang; Bijal D Shah; Salvador Bruno; Alan F List; Lynn C Moscinski; Terrence Grady; Steven J Agosti; Loveleen Kang; Ling Zhang
Journal:  Acta Haematol       Date:  2013-04-16       Impact factor: 2.195

9.  Acute lymphoblastic leukemia with eosinophilia.

Authors:  R S Fishel; J P Farnen; C A Hanson; S M Silver; S G Emerson
Journal:  Medicine (Baltimore)       Date:  1990-07       Impact factor: 1.889

Review 10.  The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.

Authors:  Tiziano Barbui; Jürgen Thiele; Heinz Gisslinger; Hans Michael Kvasnicka; Alessandro M Vannucchi; Paola Guglielmelli; Attilio Orazi; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2018-02-09       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.